166 related articles for article (PubMed ID: 36724083)
1. Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals.
Phipps MD; Cingoranelli S; Bhupathiraju NVSDK; Younes A; Cao M; Sanders VA; Neary MC; Devany MH; Cutler CS; Lopez GE; Saini S; Parker CC; Fernandez SR; Lewis JS; Lapi SE; Francesconi LC; Deri MA
Inorg Chem; 2023 Dec; 62(50):20567-20581. PubMed ID: 36724083
[TBL] [Abstract][Full Text] [Related]
2. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O
Carbo-Bague I; Saini S; Cingoranelli SJ; Davey PRWJ; Tosato M; Lapi SE; Ramogida CF
Nucl Med Biol; 2024; 128-129():108872. PubMed ID: 38262310
[TBL] [Abstract][Full Text] [Related]
4. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
[TBL] [Abstract][Full Text] [Related]
5. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
Xu J; Kullgren B; Durbin PW; Raymond KN
J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.
N Tinianow J; Pandya DN; Pailloux SL; Ogasawara A; Vanderbilt AN; Gill HS; Williams SP; Wadas TJ; Magda D; Marik J
Theranostics; 2016; 6(4):511-21. PubMed ID: 26941844
[TBL] [Abstract][Full Text] [Related]
7. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.
Deblonde GJ; Sturzbecher-Hoehne M; Abergel RJ
Inorg Chem; 2013 Aug; 52(15):8805-11. PubMed ID: 23855806
[TBL] [Abstract][Full Text] [Related]
8. Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals.
Carter KP; Deblonde GJ; Lohrey TD; Bailey TA; An DD; Shield KM; Lukens WW; Abergel RJ
Commun Chem; 2020 May; 3(1):61. PubMed ID: 36703424
[TBL] [Abstract][Full Text] [Related]
9. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.
Ioannidis I; Lefkaritis G; Georgiades SN; Pashalidis I; Kontoghiorghes GJ
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892142
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals.
Sturzbecher-Hoehne M; Choi TA; Abergel RJ
Inorg Chem; 2015 Apr; 54(7):3462-8. PubMed ID: 25799124
[TBL] [Abstract][Full Text] [Related]
11. Comparative Study of a Decadentate Acyclic Chelate, HOPO-O
Carbo-Bague I; Li C; McNeil BL; Gao Y; McDonagh AW; Van de Voorde M; Ooms M; Kunz P; Yang H; Radchenko V; Schreckenbach G; Ramogida CF
Inorg Chem; 2023 Dec; 62(50):20549-20566. PubMed ID: 36608341
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
[TBL] [Abstract][Full Text] [Related]
13. Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.
Bhupathiraju NVSDK; Younes A; Cao M; Ali J; Cicek HT; Tully KM; Ponnala S; Babich JW; Deri MA; Lewis JS; Francesconi LC; Drain CM
Org Biomol Chem; 2019 Jul; 17(28):6866-6871. PubMed ID: 31268109
[TBL] [Abstract][Full Text] [Related]
14. Folding Dynamics of 3,4,3-LI(1,2-HOPO) in Its Free and Bound State with U
Wang Q; Liu Z; Song YF; Wang D
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500244
[TBL] [Abstract][Full Text] [Related]
15. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
Zhou X; Dong L; Shen L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
[TBL] [Abstract][Full Text] [Related]
16. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
Uhlir LC; Durbin PW; Jeung N; Raymond KN
J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
[TBL] [Abstract][Full Text] [Related]
17. Competitive binding of Pu and Am with bone mineral and novel chelating agents.
Guilmette RA; Hakimi R; Durbin PW; Xu J; Raymond KN
Radiat Prot Dosimetry; 2003; 105(1-4):527-34. PubMed ID: 14527022
[TBL] [Abstract][Full Text] [Related]
18. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.
Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F
Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573
[TBL] [Abstract][Full Text] [Related]
19. [
Li L; Jaraquemada-Peláez MG; Aluicio-Sarduy E; Wang X; Jiang D; Sakheie M; Kuo HT; Barnhart TE; Cai W; Radchenko V; Schaffer P; Lin KS; Engle JW; Bénard F; Orvig C
Inorg Chem; 2020 Feb; 59(3):1985-1995. PubMed ID: 31976659
[No Abstract] [Full Text] [Related]
20. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice.
Durbin PW; Kullgren B; Ebbe SN; Xu J; Raymond KN
Health Phys; 2000 May; 78(5):511-21. PubMed ID: 10772024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
